The Janssen COVID-19 Vaccine includes the following ingredients: recombinant, replication-incompetent adenovirus type 26 expressing the SARS -CoV-2 spike protein, citric acid 3 …
Show more
See More
Janssen COVID-19 Vaccine Standing Orders (updated 2/22/22) Preparation and Administration Summary (updated 3/4/22) Vaccine administration training and clinical materials Interim COVID-19 Immunization Schedule for Ages 5+ Find …
Show more
See More
Feb 22, 2022 . The J&J/Janssen COVID-19 vaccine contains a piece of a modified virus that is not the virus that causes COVID-19. This modified virus is called the vector virus. The vector virus cannot reproduce itself, so it cannot …
Show more
See More
The Janssen COVID-19 Vaccine is supplied in a carton of 10 multi-dose vials (NDC 59676-580-15). A maximum of 5 doses of 0.5 mL can be withdrawn from the multi-dose vial (NDC 59676-580-05). The vial stoppers are not made with natural rubber latex. Storage, Dosage and Administration Guide LOGISTICS FLASH CARD Storage and Handling*
Show more
See More
The Janssen COVID‑19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID‑19) in individuals 18 years of age and older. FDA EUA Letter for the Janssen COVID-19 Vaccine
Show more
See More
Mar 25, 2022 . This information is intended for use by our customers, patients, and healthcare professionals in the United States only. Janssen Pharmaceuticals, Inc., recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country.
Show more
See More
a Janssen Pharmaceutical Company of Johnson & Johnson Authorized Use For the prevention of coronavirus disease 2019 (COVID-19) for individuals 18 years of age and older Common Side Effects The most...
Show more
See More
Affording and Accessing Our Medicines. We are committed to helping patients find the resources they need to start and stay on their Janssen medicines during the COVID-19 pandemic. Visit Janssen CarePath to learn how we’re continuing to help patients in the U.S. afford and access our medicines. Backed by the size and reach of Johnson & Johnson ...
Show more
See More
FACT SHEET FOR RECIPIENTS AND CAREGIVERS EMERGENCY USE AUTHORIZATION (EUA) OF THE JANSSEN COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER You are being offered the Janssen COVID-19 Vaccine to prevent Coronavirus Disease 2019 (COVID-19) caused by …
Show more
See More
Backed by the size and reach of Johnson & Johnson, we are transforming lives and reinventing healthcare as we tackle society's most pressing health challenges. You can count on us to never stop working toward a future where disease is a thing of the past. Find the latest Janssen news on our social media feeds.
Pharmaceutical Companies of Johnson & Johnson, please visit Janssen.com If you have product-related questions, please contact a specialist: US Toll Free: 1-800-565-40081-800-565-4008 US Toll: 1-908-455-99221-908-455-9922 © Janssen Therapeutics, Division of Janssen Products, LP 2021. All rights reserved. 12/21 cp-201876v20.
The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older. Emergency Use Authorization Status: Authorized
Visit Janssen CarePath to learn how we’re continuing to help patients in the U.S. afford and access our medicines. Backed by the size and reach of Johnson & Johnson, we are transforming lives and reinventing healthcare as we tackle society's most pressing health challenges.